BiotechTube
Home/Cyclerion Therapeutics/Steven Hyman, MD
SH

Steven Hyman, MD

Board Member

Cyclerion Therapeutics

Therapeutic Areas

NeuropsychiatryCentral Nervous System (CNS)

Cyclerion Therapeutics Pipeline

DrugIndicationPhase
CYC-126Treatment-Resistant Depression (TRD)Phase 1

Leadership Team at Cyclerion Therapeutics

RG
Regina Graul, PhD
President, Chief Executive Officer, Board Member
RC
Rhonda Chicko, CPA
Chief Financial Officer
ED
Errol De Souza, PhD
Chairman of the Board
PH
Peter Hecht, PhD
Board Member
MH
Michael Higgins
Board Member
DK
Dina Katabi, PhD
Board Member
HM
Husseini Manji, MD, FRCPC
Clinical Advisory Board
View full Cyclerion Therapeutics profile